Pyrazoline derivatives as promising novel antischistosomal agents

Praziquantel is the only available drug to treat schistosomiasis, a parasitic disease that currently infects more than 240 million people globally. Due to increasing concerns about resistance and inadequate efficacy there is a need for new therapeutics. In this study, a series of 17 pyrazolines (15–...

Descripción completa

Detalles Bibliográficos
Autores principales: Morais, Cristiane S., Mengarda, Ana C., Miguel, Fábio B., Enes, Karine B., Rodrigues, Vinícius C., Espírito-Santo, Maria Cristina C., Siyadatpanah, Abolghasem, Wilairatana, Polrat, Couri, Mara R. C., de Moraes, Josué
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648852/
https://www.ncbi.nlm.nih.gov/pubmed/34873205
http://dx.doi.org/10.1038/s41598-021-02792-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648852/
https://www.ncbi.nlm.nih.gov/pubmed/34873205
http://dx.doi.org/10.1038/s41598-021-02792-0

Ejemplares similares